Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Methylphenidate Raclopride PET Test

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00015301

Enrollment

Registered

2001-04-18

Start date

2003-12-31

Completion date

2005-08-31

Last updated

2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders, Substance-Related Disorders

Brief summary

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Detailed description

The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Interventions

DRUGMethylphenidate

Study design

Primary purpose

DIAGNOSTIC

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

Healthy normals

Exclusion criteria

History of head trauma or loss of consciousness. Significant medical history. History of seizures.

Design outcomes

Primary

Measure	Time frame
Dopamine receptor availability	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026